Financial Year |
March 31 2023 |
Monetary Funds |
210,447,048,500.00 |
Held-for-trading Financial Assets |
1,496,062,900.00 |
Notes Receivable |
4,845,153,200.00 |
Accounts Receivable |
48,606,965,200.00 |
Advances to Suppliers |
14,877,912,400.00 |
Other Receivables |
4,578,122,900.00 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
64,037,677,300.00 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
407,644,900.00 |
Other Current Assets |
12,242,046,600.00 |
Total Current Assets |
389,446,165,900.00 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
42,548,700.00 |
Long-term Equity Investment |
44,003,247,000.00 |
Investment Properties |
-- |
Fixed Assetes |
96,611,233,400.00 |
Under-construction Projects |
32,354,331,800.00 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
17,562,949,500.00 |
R&D expenses |
-- |
Goodwill |
715,160,700.00 |
Long-Term Deferred and Prepaid Expenses |
3,801,140,400.00 |
Deferred Income Tax Assets |
10,370,303,200.00 |
Other Non-Current Assets |
26,375,928,900.00 |
Sub-Total of Non-Current Assets |
250,757,411,600.00 |
Total Assets |
640,203,577,500.00 |
Short-Term Loans |
14,876,987,000.00 |
Trading Financial liabilities |
-- |
Notes Payable |
114,125,383,600.00 |
Accounts Payable |
92,008,949,000.00 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
10,213,306,300.00 |
Taxes Payable |
5,239,122,700.00 |
Interest Payable |
-- |
Dividend Payable |
6,173,956,200.00 |
Other payables |
21,940,135,700.00 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
3,980,597,800.00 |
Other Current Liabilities |
1,769,661,400.00 |
Sub-Total of Current Liabilities |
290,026,712,800.00 |
Long-term Loans |
68,376,274,800.00 |
Bonds Payable |
18,969,611,400.00 |
Long-Term Accounts Payable |
1,200,000,000.00 |
Special Payable |
-- |
Estimatied Liabilities |
21,992,362,200.00 |
Deferred Income Tax Liabilities |
3,206,405,500.00 |
Other Non-Current Liabilities |
6,685,434,300.00 |
Sub-Total of Non-Current Liabilities |
141,456,422,200.00 |
Total Liabilities |
431,483,135,000.00 |
Paid-In Capital(Or Share Stock) |
2,442,385,000.00 |
Capital Surplus |
108,494,320,100.00 |
Surplus Reserve |
1,214,302,900.00 |
LESS:Treasury Stock |
249,411,800.00 |
Undistributed Profits |
70,047,213,300.00 |
Minority Stockholder's Interest |
20,813,483,100.00 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
187,906,959,400.00 |
Owner's Equity(Stockholder's Equity) |
208,720,442,500.00 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
640,203,577,500.00 |